Sano, C., Shimizu, T., Sato, K., Kawauchi, H., Kawahara, S., & Tomioka, H. (1999). Therapeutic Effects of Benzoxazinorifamycin KRM-1648 Administered Alone or in Combination with a Half-Sized Secretory Leukocyte Protease Inhibitor or the Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium against Mycobacterium avium Complex Infection in Mice. American Society for Microbiology.
Citação norma ChicagoSano, Chiaki, Toshiaki Shimizu, Katsumasa Sato, Hideyuki Kawauchi, Shin Kawahara, and Haruaki Tomioka. Therapeutic Effects of Benzoxazinorifamycin KRM-1648 Administered Alone or in Combination With a Half-Sized Secretory Leukocyte Protease Inhibitor or the Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium against Mycobacterium Avium Complex Infection in Mice. American Society for Microbiology, 1999.
ציטוט MLASano, Chiaki, et al. Therapeutic Effects of Benzoxazinorifamycin KRM-1648 Administered Alone or in Combination With a Half-Sized Secretory Leukocyte Protease Inhibitor or the Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium against Mycobacterium Avium Complex Infection in Mice. American Society for Microbiology, 1999.